MassMutual Private Wealth & Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $158K | Sell |
733
-17
| -2% | -$3.25K | ﹤0.01% | 485 |
|
|
2026
Q1 | $137K | Sell |
750
-10
| -1% | -$1.84K | ﹤0.01% | 511 |
|
|
2025
Q4 | $134K | Buy |
760
+34
| +5% | +$5.55K | ﹤0.01% | 535 |
|
|
2025
Q3 | $102K | Buy |
726
+109
| +18% | +$14.7K | ﹤0.01% | 593 |
|
|
2025
Q2 | $77.5K | Buy |
617
+107
| +21% | +$13.3K | ﹤0.01% | 664 |
|
|
2025
Q1 | $69.8K | Buy |
510
+238
| +88% | +$34K | ﹤0.01% | 646 |
|
|
2024
Q4 | $41.6K | Sell |
272
-104
| -28% | -$17.5K | ﹤0.01% | 791 |
|
|
2024
Q3 | $72.9K | Sell |
376
-118
| -24% | -$24.7K | ﹤0.01% | 582 |
|
|
2024
Q2 | $115K | Buy |
494
+161
| +48% | +$35K | ﹤0.01% | 495 |
|
|
2024
Q1 | $71.8K | Buy |
333
+92
| +38% | +$21.5K | ﹤0.01% | 537 |
|
|
2023
Q4 | $62.4K | Buy |
241
+10
| +4% | +$2.46K | ﹤0.01% | 550 |
|
|
2023
Q3 | $59.4K | Sell |
231
-23
| -9% | -$6.15K | ﹤0.01% | 546 |
|
|
2023
Q2 | $72.4K | Buy |
254
+54
| +27% | +$16.1K | ﹤0.01% | 483 |
|
|
2023
Q1 | $55.6K | Buy |
200
+84
| +72% | +$23.2K | ﹤0.01% | 503 |
|
|
2022
Q4 | $32K | Buy |
116
+8
| +7% | +$2.26K | ﹤0.01% | 537 |
|
|
2022
Q3 | $29K | Buy |
108
+24
| +29% | +$5.1K | ﹤0.01% | 528 |
|
|
2022
Q2 | $17K | Buy |
84
+11
| +15% | +$2.25K | ﹤0.01% | 603 |
|
|
2022
Q1 | $15K | Buy |
73
+55
| +306% | +$12K | ﹤0.01% | 648 |
|
|
2021
Q4 | $4K | Sell |
18
-32
| -64% | -$8.23K | ﹤0.01% | 931 |
|
|
2021
Q3 | $14K | Sell |
50
-10,998
| -100% | -$3.6M | ﹤0.01% | 649 |
|
|
2021
Q2 | $3.83M | Sell |
11,048
-227
| -2% | -$68.8K | 0.16% | 137 |
|
|
2021
Q1 | $3.15M | Buy |
11,275
+256
| +2% | +$69K | 0.15% | 143 |
|
|
2020
Q4 | $2.7M | Sell |
11,019
-902
| -8% | -$233K | 0.14% | 141 |
|
|
2020
Q3 | $3.38M | Sell |
11,921
-157
| -1% | -$43.8K | 0.2% | 125 |
|
|
2020
Q2 | $3.23M | Buy |
12,078
+503
| +4% | +$151K | 0.21% | 127 |
|
|
2020
Q1 | $3.66M | Sell |
11,575
-109
| -0.9% | -$33.1K | 0.29% | 86 |
|
|
2019
Q4 | $3.47M | Sell |
11,684
-78
| -0.7% | -$21.6K | 0.21% | 125 |
|
|
2019
Q3 | $2.74M | Sell |
11,762
-826
| -7% | -$192K | 0.18% | 134 |
|
|
2019
Q2 | $2.94M | Sell |
12,588
-1,487
| -11% | -$343K | 0.2% | 126 |
|
|
2019
Q1 | $3.33M | Buy |
14,075
+291
| +2% | +$91.6K | 0.24% | 115 |
|
|
2018
Q4 | $4.15M | Buy |
13,784
+144
| +1% | +$46K | 0.36% | 76 |
|
|
2018
Q3 | $4.82M | Sell |
13,640
-1,191
| -8% | -$410K | 0.36% | 71 |
|
|
2018
Q2 | $4.3M | Buy |
14,831
+1,400
| +10% | +$394K | 0.34% | 69 |
|
|
2018
Q1 | $3.68M | Buy |
13,431
+726
| +6% | +$225K | 0.3% | 88 |
|
|
2017
Q4 | $4.05M | Buy |
12,705
+1,574
| +14% | +$505K | 0.34% | 79 |
|
|
2017
Q3 | $3.49M | Buy |
11,131
+192
| +2% | +$56.9K | 0.29% | 99 |
|
|
2017
Q2 | $2.97M | Sell |
10,939
-3,330
| -23% | -$881K | 0.26% | 109 |
|
|
2017
Q1 | $3.9M | Buy |
14,269
+787
| +6% | +$223K | 0.37% | 84 |
|
|
2016
Q4 | $3.82M | Buy |
+13,482
| New | +$4M | 0.47% | 61 |
|
|
2016
Q2 | $794K | Buy |
3,285
+700
| +27% | +$184K | 0.1% | 192 |
|
|
2016
Q1 | $673K | Buy |
2,585
+157
| +6% | +$41.5K | 0.09% | 196 |
|
|
2015
Q4 | $744K | Sell |
2,428
-2,335
| -49% | -$671K | 0.11% | 175 |
|
|
2015
Q3 | $1.58M | Buy |
4,763
+835
| +21% | +$276K | 0.33% | 78 |
|
|
2015
Q2 | $1.24M | Sell |
3,928
-1,387
| -26% | -$557K | 0.28% | 93 |
|
|
2015
Q1 | $2.24M | Buy |
5,315
+1,782
| +50% | +$702K | 0.37% | 67 |
|
|
2014
Q4 | $1.2M | Sell |
3,533
-1,230
| -26% | -$398K | 0.39% | 81 |
|
|
2014
Q3 | $1.58M | Buy |
4,763
+835
| +21% | +$275K | 0.31% | 81 |
|
|
2014
Q2 | $1.24M | Buy |
3,928
+736
| +23% | +$222K | 0.49% | 47 |
|
|
2014
Q1 | $976K | Buy |
3,192
+1,957
| +158% | +$621K | 0.57% | 46 |
|
|
2013
Q4 | $345K | Buy |
+1,235
| New | +$319K | 0.32% | 65 |
|
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
MassMutual Private Wealth & Trust's BIIB Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Biogen (BIIB) stake by 2.3% in Q2 2026, selling an estimated $3.25K and leaving 733 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #485.
MassMutual Private Wealth & Trust first reported a position in BIIB in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.82M in Q3 2018. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- MassMutual Private Wealth & Trust held 733 shares of Biogen worth $158K as of Q2 2026.
- MassMutual Private Wealth & Trust sold 17 Biogen shares in Q2 2026, an estimated $3.25K.
- Biogen made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #485 holding.
- MassMutual Private Wealth & Trust first reported a position in Biogen in Q4 2013 and has held it in 50 quarters since.
- MassMutual Private Wealth & Trust's Biogen position peaked at $4.82M in Q3 2018.
- 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.